Reed L. Benson's Insider Trades & SAST Disclosures
Reed L. Benson's most recent trade in Co-Diagnostics Inc was a trade of 4,584 Restricted Stock Units done . Disclosure was reported to the exchange on May 24, 2021.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Reed L. Benson.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Co-Diagnostics Inc | Reed L. Benson | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2021 | 4,584 | 22,916 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | Reed L. Benson | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2021 | 4,584 | 4,584 (0%) | 0% | 0 | Common Stock | |
| Co-Diagnostics Inc | Reed L. Benson | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.90 per share. | 24 May 2021 | 1,414 | 3,170 (0%) | 0% | 7.9 | 11,170 | Common Stock |
| Co-Diagnostics Inc | Reed L. Benson | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.63 per share. | 19 May 2021 | 97,413 | 108,334 (0%) | 0% | 2.6 | 256,196 | Common Stock |
| Co-Diagnostics Inc | Reed L. Benson | General Counsel | Sale of securities on an exchange or to another person at price $ 8.52 per share. | 19 May 2021 | 97,413 | 1 (0%) | 0% | 8.5 | 830,387 | Common Stock |
| Co-Diagnostics Inc | Reed L. Benson | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2021 | 97,413 | 0 | - | - | Stock Option (Right to Buy) | |
| Co-Diagnostics Inc | Reed L. Benson | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2021 | 10,920 | 0 | - | - | Stock Option (Right to Buy) | |
| Co-Diagnostics Inc | Reed L. Benson | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.63 per share. | 19 May 2021 | 10,920 | 10,921 (0%) | 0% | 2.6 | 28,720 | Common Stock |
| Co-Diagnostics Inc | Reed L. Benson | General Counsel | Sale of securities on an exchange or to another person at price $ 8.54 per share. | 19 May 2021 | 10,920 | 97,414 (0%) | 0% | 8.5 | 93,232 | Common Stock |
| Co-Diagnostics Inc | Reed L. Benson | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.00 per share. | 19 May 2021 | 1 | 1 (0%) | 0% | 1 | 1 | Common Stock |
| Co-Diagnostics Inc | Reed L. Benson | General Counsel | Sale of securities on an exchange or to another person at price $ 9.00 per share. | 19 May 2021 | 1 | 0 (0%) | 0% | 9 | 9 | Common Stock |
| Co-Diagnostics Inc | Reed L. Benson | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2021 | 1 | 13,891 | - | - | Stock Option (Right to Buy) | |
| Co-Diagnostics Inc | Reed L. Benson | CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2020 | 100,000 | 25,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Co-Diagnostics Inc | Reed L. Benson | CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.10 per share. | 25 Nov 2020 | 100,000 | 100,000 (0%) | 0% | 1.1 | 110,000 | Common Stock |
| Co-Diagnostics Inc | Reed L. Benson | CFO and Secretary | Sale of securities on an exchange or to another person at price $ 10.50 per share. | 25 Nov 2020 | 89,524 | 0 (0%) | 0% | 10.5 | 940,002 | Common Stock |
| Co-Diagnostics Inc | Reed L. Benson | CFO and Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.10 per share. | 25 Nov 2020 | 10,476 | 89,524 (0%) | 0% | 1.1 | 11,524 | Common Stock |
| Co-Diagnostics Inc | Reed L. Benson | CFO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Nov 2020 | 27,500 | 27,500 | - | - | Restricted Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges